Regulators of mitotic arrest and ceramide metabolism are determinants of sensitivity to paclitaxel and other chemotherapeutic drugs
Charles Swanton, Michela Marani, Olivier Pardo, Patricia H Warne, Gavin Kelly, Erik Sahai, Frédéric Elustondo, Jenny Chang, Jillian Temple, Ahmed A Ahmed, James D Brenton, Julian Downward, Barbara Nicke, Charles Swanton, Michela Marani, Olivier Pardo, Patricia H Warne, Gavin Kelly, Erik Sahai, Frédéric Elustondo, Jenny Chang, Jillian Temple, Ahmed A Ahmed, James D Brenton, Julian Downward, Barbara Nicke
Abstract
Cytotoxic drug resistance is a major cause of cancer treatment failure. We report an RNA interference screen to identify genes influencing sensitivity of different cancer cell types to chemotherapeutic agents. A set of genes whose targeting leads to resistance to paclitaxel is identified, many of which are involved in the spindle assembly checkpoint. Silencing these genes attenuates paclitaxel-induced mitotic arrest and induces polyploidy in the absence of drug. We also identify a ceramide transport protein, COL4A3BP or CERT, whose downregulation sensitizes cancer cells to multiple cytotoxic agents, potentiating endoplasmic reticulum stress. COL4A3BP expression is increased in drug-resistant cell lines and in residual tumor following paclitaxel treatment of ovarian cancer, suggesting that it could be a target for chemotherapy-resistant cancers.
Source: PubMed